⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL235481 | 0.55 | — | — | |
| SCHEMBL452580 | 0.49 | — | — | |
| SCHEMBL43805 | 0.39 | — | — | |
| SCHEMBL5134172 | 0.39 | — | — | |
| SCHEMBL12992748 | 0.35 | — | — | |
| SCHEMBL10784011 | 0.32 | — | — | |
| SCHEMBL4846857 | 0.26 | — | — | |
| SCHEMBL30912984 | 0.26 | — | — | |
| SCHEMBL6559802 | 0.26 | — | — | |
| Methane SCHEMBL21980775 | 0.26 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 596 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3959200-A1 | NEW TRIAZOLE AND TRIAZOLOTHIADIAZINE DERIVATIVES EXERTING CYTOTOXIC AND APOPTOTIC EFFECTS ON A549 CELLS THROUGH AKT INHIBITION | Anadolu Universitesi (TR) | 2022-03-02 | — | — | EP | claimed |
| WO-2021257020-A1 | TARGETED NOVEL TRIAZOLOTHIADIAZINE DERIVATIVES FOR THE TREATMENT OF LUNG CANCER | ANADOLU ÜNİVERSİTESİ (TR) | 2021-12-23 | — | — | WO | claimed |
| CN-111454232-B | 1,3, 4-thiadiazine compound and application thereof | 南方医科大学 | 2021-11-23 | — | — | CN | claimed |
| CN-111454232-A | 1,3, 4-thiadiazine compound and application thereof | 南方医科大学 | 2020-07-28 | — | — | CN | claimed |
| US-9981257-B2 | Metal-ligand catalyst formation | INVISTA NORTH AMERICA S.A.R.L. (US) | 2018-05-29 | — | — | US | claimed |
| CN-103889576-B | Improvements in nickel metal ligand catalyst formation | 因温斯特技术公司 | 2017-06-23 | — | — | CN | claimed |
| CN-103889576-A | Improvements in nickel metal ligand catalyst formation | INVISTA TECH SARL | 2014-06-25 | — | — | CN | claimed |
| EP-2718015-A2 | IMPROVEMENT IN NICKEL METAL-LIGAND CATALYST FORMATION | Invista Technologies S.à.r.l. (CH) | 2014-04-16 | — | — | EP | claimed |
| US-20130143730-A1 | METAL-LIGAND CATALYST FORMATION | INVISTA NORTH AMERICA S.A.R.L. (US) | 2013-06-06 | — | — | US | claimed |
| WO-2012170300-A2 | IMPROVEMENT IN METAL-LIGAND CATALYST FORMATION | INVISTA TECHNOLOGIES S.A R.L. (CH) | 2012-12-13 | — | — | WO | claimed |
| US-20040152690-A1 | Vanilloid receptor ligands and their use in treatments | AMGEN INC. | 2004-08-05 | — | — | US | claimed |
| US-20040082780-A1 | Vanilloid receptor ligands and their use in treatments | AMGEN, INC. | 2004-04-29 | — | — | US | claimed |
| WO-2004035549-A1 | BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS VANILLOID RECEPTOR LIGANDS | AMGEN INC. (US) | 2004-04-29 | — | — | WO | claimed |
| US-20040038969-A1 | Vanilloid receptor ligands and their use in treatments | AMGEN, INC. | 2004-02-26 | — | — | US | claimed |
| WO-2004014871-A1 | VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS | AMGEN INC. (US) | 2004-02-19 | — | — | WO | claimed |
| WO-2003099284-A1 | AMINO-PYRIDINE, -PYRIDINE AND PYRIDAZINE DERIVATIVES FOR USE AS VANILLOID RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN | AMGEN INC. (US) | 2003-12-04 | — | — | WO | claimed |
| US-20030195201-A1 | Vanilloid receptor ligands and their use in treatments | AMGEN INC. | 2003-10-16 | — | — | US | claimed |
| WO-2003049702-A2 | VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS | AMGEN INC. (US) | 2003-06-19 | — | — | WO | claimed |
| US-5536633-A | NEGATIVE PHOTOGRAPHIC FILMS | EASTMAN KODAK COMPANY (US) | 1996-07-16 | — | — | US | claimed |
| WO-1992018484-A1 | 3-AMINO-5-ARYLPYRAZOLE-4-ACETIC ACID DERIVATIVES EXHIBITING THERAPEUTIC EFFECTS | A.H. ROBINS COMPANY, INCORPORATED (US) | 1992-10-29 | — | — | WO | claimed |